A Real-World Experience on a Chinese Population of Patients With Unresectable Hepatocellular Carcinoma Treated With Nivolumab.
Shou-Wu LeeSheng-Shun YangTeng-Yu Lee
Published in: Gastroenterology research (2024)
Decline in AFP during therapy has a predicting role on HCC radiological responses to nivolumab. Achieving radiological responses had better survival outcomes.